Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

More Medicare pricing data

This article was originally published in The Gray Sheet

Executive Summary

CMS posts payment rates and hospital volume data to its website Nov. 20 for 91 common physician services and 81 procedures performed in the hospital outpatient setting. The information adds to previously posted data on inpatient and ambulatory surgical center procedures and furthers President Bush's August executive order aimed at stimulating transparency in healthcare pricing and quality (1"The Gray Sheet" Aug. 28, 2006, p. 16)...

You may also be interested in...



Administration Unveils Transparency Initiatives; Private Sector Follows Suit

The Bush Administration took several steps last week in its agenda for improving public access to price and quality information on healthcare procedures, and some private insurers have followed suit

Belgium Aims To Drive Biologic Competition Through Tendering

New tendering rules in Belgium aim to improve competition between biosimilars and originators, for example by setting contract durations for tendering contracts and limiting the criteria for such contracts.

EU Bodies Agree On Ways To Future-Proof EMA Funding System

EU ministers say that implementing an appropriate fee structure that is more in line with actual costs will promote innovation in the pharmaceutical sector while ensuring “fair access” to safe and effective medicines for patients.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024234

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel